An inexpensive, over-the-counter form of vitamin B3 cut new skin cancers by an average of 14% in a study of more than 33,000 people. Among those who began taking a daily dose after a first diagnosis, the risk of a repeat skin cancer fell by up to 54%. Source of Article
Adding to the growing body of evidence supporting the health benefits of cramming all your weekly exercise into two days, a large new study has found that it can significantly reduce the risk of cardiovascular mortality in adults with diabetes. Source of Article
The US Food and Drug Administration has instructed all GLP-1 drug-makers to update warning labels to include the risk of serious kidney injury that can result from dehydration. This comes after cases of acute kidney injury have required hemodialysis. Source of Article
A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use an automated insulin delivery system. It’s hoped this will lead to the approval of Ozempic for this patient population. Source of Article
Over the weekend, Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing what appears to be a strategic "something for everyone" plan of attack from the pharmaceutical giant. Source of Article
Researchers have identified a protein that represses the activity of energy-burning brown fat. The discovery opens the door to developing treatments for the extreme weight loss, muscle wasting, and malnutrition seen in some types of cancer. Source of Article
Soft corals produce chemicals that could be used to treat human disease. Now, scientists have identified the genes that make these important chemicals, opening the door to creating a limitless supply that can be used to produce and test new drugs. Source of Article
The sea cucumber naturally produces a sugary compound that inhibits an enzyme that’s instrumental in stimulating cancer growth, according to a new study. The next step is to find a method for producing the compound in large quantities. Source of Article
The sea cucumber naturally produces a sugary compound that inhibits an enzyme that’s instrumental in stimulating cancer growth, according to a new study. The next step is to find a method for producing the compound in large quantities. Source of Article
The sea cucumber naturally produces a sugary compound that inhibits an enzyme that’s instrumental in stimulating cancer growth, according to a new study. The next step is to find a method for producing the compound in large quantities. Source of Article
Copyright © 2025 Nasni Consultants Ltd. All Rights Reserved